AVTX — AVALO THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 136 家机构在其最新 13F 申报中持有 AVTX(AVALO THERAPEUTICS INC),合计申报市值 $1.32B,对应 72.93M 股。按股数计算较上季度增持 112.9%(+29.15M 股),申报市值环比上升 163.6%。持仓集中度较高:前五大持有人占申报市值的 26.9%,前十大的集中度为 44.5%。
与上一季度相比,59 家新建仓位、49 家加仓、20 家减仓、29 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
AVALO THERAPEUTICS INC(AVTX)的主要机构持有人包括 Fidelity Management & Research (FMR)、BlackRock Inc、Deep Track Capital, LP,按 13F 申报市值在本页 224 家持有人中排名居前。
AVTX 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 90 | 28.73M | $438.14M | +13.9% |
| Q2 2026 | 136 | 72.93M | $1.32B | +112.9% |
| Q1 2026 | 106 | 32.75M | $488.69M | +34.0% |
| Q4 2025 | 86 | 20.27M | $368.01M | +19.4% |
| Q3 2025 | 66 | 14.90M | $189.36M | +20.9% |
| Q2 2025 | 35 | 7.84M | $39.11M | -4.2% |
| Q1 2025 | 32 | 8.15M | $65.27M | -11.2% |
| Q4 2024 | 32 | 7.46M | $55.41M | +15.6% |
表内 8 个季度中,机构持股合计增加 285%(Q4 2024 → Q3 2026);单季变动最大的是 Q2 2026(+112.9%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.36M | $24.61M | 0.83% | 持有 | |
| 1.24M | $22.43M | 1.12% | 持有 | |
| 1.19M | $21.56M | 0.46% | 减持 | |
| 1.05M | $19.09M | 1.16% | 增持 | |
| 881.53K | $16.01M | 1.50% | 增持 | |
| 804.08K | $14.60M | 0.00% | 增持 | |
| 662.97K | $12.04M | 0.12% | 持有 | |
| 659.98K | $11.99M | 0.01% | 增持 | |
| 659.98K | $11.99M | 0.02% | 增持 | |
| 627.50K | $11.40M | 0.04% | 减持 | |
| 621.35K | $11.28M | 0.00% | 增持 | |
| 550.00K | $9.99M | 0.01% | 增持 | |
| 524.44K | $9.52M | 1.45% | 减持 | |
| 507.55K | $9.22M | 0.01% | 增持 | |
| 483.00K | $8.77M | 0.58% | 持有 | |
| 483.00K | $8.77M | 0.29% | 持有 | |
| 477.82K | $8.68M | 0.01% | 增持 | |
| 475.62K | $8.64M | 0.01% | 新进 | |
| 441.98K | $8.03M | 0.30% | 新进 | |
| 439.31K | $7.98M | 0.03% | 减持 | |
| 419.49K | $7.62M | 0.01% | 增持 | |
| 311.97K | $5.67M | 1.21% | 增持 | |
| 289.57K | $5.26M | 0.00% | 增持 | |
| 275.00K | $4.99M | 1.09% | 增持 | |
| 264.91K | $4.81M | 0.00% | 增持 |
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 1.03M | $5.13M | 0.18% | 减持 | |
| 995.00K | $4.97M | 0.22% | 增持 | |
| 967.00K | $4.83M | 0.13% | 持有 | |
| 932.97K | $4.66M | 0.08% | 减持 | |
| 607.87K | $3.03M | 0.47% | 减持 | |
| 567.10K | $2.83M | 0.09% | 减持 | |
| 483.00K | $2.41M | 0.17% | 持有 | |
| 483.00K | $2.41M | 0.28% | 持有 | |
| 406.57K | $2.03M | 0.00% | 增持 | |
| 261.02K | $1.30M | 0.02% | 减持 | |
| 166.94K | $833.04K | 0.00% | 持有 | |
| 155.90K | $777.94K | 0.00% | 增持 | |
| 154.97K | $773.31K | 0.76% | 增持 | |
| 139.67K | $696.94K | 0.03% | 减持 | |
| 110.46K | $551.61K | 0.00% | 增持 | |
| 104.73K | $522.60K | 0.09% | 增持 | |
| 83.72K | $417.78K | 0.00% | 减持 | |
| 72.17K | $360.14K | 0.14% | 增持 | |
| 35.30K | $176.15K | 0.06% | 减持 | |
| 22.67K | $113.14K | 0.00% | 持有 | |
| 20.61K | $102.86K | 0.00% | 增持 | |
| 12.89K | $64.32K | 0.00% | 新进 | |
| 11.32K | $56.49K | 0.00% | 新进 | |
| 10.98K | $54.77K | 0.00% | 新进 | |
| 4.00K | $19.00K | 0.00% | 新进 |
新建仓(Q2 2026)
- Deep Track Capital, LP 3.61M 股 · $66.71M
- BRAIDWELL LP 1.63M 股 · $30.11M
- PRICE T ROWE ASSOCIATES INC /MD/ 1.31M 股 · $24.24M
- ALLIANCEBERNSTEIN L.P. 1.26M 股 · $23.30M
- GEODE CAPITAL MANAGEMENT, LLC 1.11M 股 · $20.43M
- Trails Edge Capital Partners, LP 891.88K 股 · $16.48M
- Vestal Point Capital, LP 775.00K 股 · $14.32M
- Parkman Healthcare Partners LLC 766.29K 股 · $14.16M
- BAKER BROS. ADVISORS LP 550.00K 股 · $10.16M
- SILVERARC CAPITAL MANAGEMENT, LLC 500.40K 股 · $9.25M
- Davern Capital Partners, LP 468.67K 股 · $8.66M
- Franklin Resources 404.19K 股 · $7.47M
完全清仓(较上季)
- T. Rowe Price Investment Management, Inc. 卖出 2.16M 股 · $32.29M
- Millennium Management 卖出 835.48K 股 · $12.47M
- MILLENNIUM MANAGEMENT LLC 卖出 835.48K 股 · $12.47M
- ORBIMED ADVISORS LLC 卖出 475.17K 股 · $7.09M
- JENNISON ASSOCIATES LLC 卖出 470.77K 股 · $7.03M
- KENNEDY CAPITAL MANAGEMENT LLC 卖出 387.98K 股 · $5.79M
- DV Trading LLC 卖出 360.06K 股 · $5.38M
- Qube Research & Technologies Ltd 卖出 174.51K 股 · $2.61M
- Hudson Bay Capital Management LP 卖出 161.09K 股 · $2.41M
- Exome Asset Management LLC 卖出 159.34K 股 · $2.38M
- STEMPOINT CAPITAL LP 卖出 134.74K 股 · $2.01M
- Marshall Wace 卖出 129.14K 股 · $1.93M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 5.25M | 5.10M | 2.88M | 220.30K | — | — | — | — | 1 | 2 | — | — | — | — | — | 13 | 35 | 1.22K | 249 | — |
| BlackRock Inc | 4.96M | 4.37M | 327.08K | 289.57K | 154.25K | 155.90K | 133.73K | 133.24K | 329 | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 3.24M | 2.90M | 1.34M | 1.05M | 1.01M | 607.87K | 657.15K | 550.76K | 45.00K | 45.00K | 10.00K | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.56M | — | 71.65K | 79.25K | 45.45K | — | — | — | — | — | — | — | 25.64K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.26M | 2.26M | 719.69K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 2.14M | 1.86M | 1.24M | 1.24M | 1.24M | 995.00K | 900.00K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.26M | 1.11M | 169.89K | 166.15K | 104.19K | 110.46K | 107.81K | 104.85K | 10.11K | — | — | — | 133.52K | 80.97K | 51.33K | 51.33K | 51.42K | 846.39K | 1.36M | 1.33M |
| UBS Group AG | 770.06K | 1.21M | 1.14M | 477.82K | 45.21K | 83.72K | 98.95K | 98.52K | 6.13K | 3.58K | 7.71K | 2 | 112 | 1.92K | 2.35K | 6.18K | 6.76K | 8.53K | 22.39K | 17.79K |
| Davern Capital Partners, LP | 564.44K | 468.67K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pivotal bioVenture Partners Investment Advisor LLC | 434.03K | 434.03K | 295.93K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 432.67K | 284.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 410.51K | — | 48.10K | — | — | — | 10.29K | 40.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 333.32K | 324.81K | 86.43K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fisher Asset Management, LLC | 316.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 275.00K | 275.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Eagle Health Investments LP | 235.09K | 235.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 223.91K | 122.17K | 171.68K | 95.43K | 72.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 221.29K | 134.09K | 422.78K | 197.75K | 5 | 5 | 4 | 4 | 4 | 4 | 4 | — | — | — | — | — | — | — | — | — |
| Verition Fund Management LLC | 210.33K | 38.24K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NAN FUNG TRINITY (HK) Ltd | 189.00K | 189.00K | 189.00K | 189.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold AVTX?
As of 2026-Q2, 136 institutional funds reported holding AVTX (AVALO THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $1.32B.
How many shares of AVTX do institutions own?
13F filers reported 72.93M shares of AVTX, worth $1.32B in aggregate at the end of 2026-Q2.
Is institutional ownership of AVTX rising or falling?
Share counts moved +112.9% versus the prior quarter — accumulation.
Who are the top institutional holders of AVTX?
The largest 13F holders are Fidelity Management & Research (FMR), BlackRock Inc, Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of AVALO THERAPEUTICS INC?
The major shareholders of AVALO THERAPEUTICS INC (AVTX) by reported 13F value are Fidelity Management & Research (FMR), BlackRock Inc, Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC, among 224 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.